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i:10.1016/j.ejvs.2009.12.022In this issue of the Journal, T. Kukkonen et al.1 evaluate the
reproducibility of femoropopliteal TASC II classification2 by
reviewing 200 angiograms of patients having femo-
ropopliteal occlusive arterial lesions. Seven investigators
evaluated the first 100 angiograms with the help of the
TASC II guide followed by a debate of the 25 most difficult
cases with a panel of 22 vascular surgeons. After the
debate, the seven investigators reviewed the 100 remaining
cases independently.
After the first evaluation, agreement between all
observers as measured by the kappa was 0.32 [0.11e0.54]
between two observers, increasing after the debate to 0.49
but remaining below the adequate inter-rater agreement of
0.70. Total agreement between all seven observers was
reached only in 7% and 19%, respectively, of the cases
before and after the debate.
This interesting study confirms a well known weakness of
the TASC II document that was predicted by the authors of
TASC II when they wrote: ‘‘It must be understood that most
PAD requiring intervention is characterized by more thanjvs.2009.11.008.
950 0550.
ty for Vascular Surgery. Publisheone lesion, at more than one level, so these schemes are
limited by the necessity to focus on individual lesions’’.2
Nevertheless, the poor intra- and interobserver reliability
of TASC II observed in this study is a timely reminder that it
is difficult to restrain the anatomical diversity of femo-
ropopliteal arterial lesions by applying a rigid classification.
In this series there were lesions not fitting in any of the
TASC classes. TASC II classification has other limitations: it
combines stenoses and occlusions, and it does not outline
the degree of the stenosis. In addition, complex arterial
lesions with, on the same artery, segments of mild and
severe stenoses are difficult to classify as single or multiple.
But TASC II classification gives at least a ‘‘rough’’ guidance
for the management of these femoropopliteal lesions.
Kukkonen et al.1 have shown also that the morphological
classification of the lesions changed from TASC I3 to TASC II,
probably because of the evolution of surgical and endo-
vascular techniques. As stressed by the authors, this makes
comparisons particularly difficult when both techniques
and classification are changing over time. This is particu-
larly true for femoropopliteal and tibial lesions.
However, we should have in mind that TASC was the first
consensus of its kind aiming at standardizing arterial lesions
in PAOD to compare different treatments for similar
lesions. The TASC II document was initiated in 2004 andd by Elsevier Ltd. All rights reserved.
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lesions have changed and will continue to change. An
update of the TASC II document is awaited shortly.
It is obvious from the above discussion that while the
basic concepts of TASC classification have been agreed
upon, the common use of this classification for decision
making and for reporting outcomes has been and will likely
continue to be the source of much debate. However before
TASC classification was developed, there were serious
problems in interpreting reports on the management of
PAOD. TASC classification is a trend in the right direction.
TASC II has limitations: some with little modification can
continue to serve as a valuable standard, and although
some of these limitations are not totally correctable, if
understood properly, these should not interfere with an
appropriate application. We hope that the controversy
brought by Kukkonen et al. will suggest improvements for
future TASC documents.Conflict of Interest
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